Sunday, March 07, 2021 10:36:56 PM
Press Release | 03/04/2021
Dr. Edward White Appointed to the Board of Directors of W Technologies, Inc.
PR Newswire
BEVERLY HILLS, Calif., March 4, 2021
BEVERLY HILLS, Calif., March 4, 2021 /PRNewswire/ -- W Technologies, Inc., ("W Tech or the Company"), (OTC:WTCG) announced today that Dr. Edward White will join the Board of Directors, effective on March 8, 2021.
By Dr. White joining our Board, W Technologies will benefit because of his extensive knowledge and experience in the medical field said Mikael Lundgren, CEO of W Tech.
Dr. White currently is a consultant in Family Practice and in Emergency Room Practice at the American Hospital in Dubai and is the owner of Princeton Medical Solutions. Dr. White has also served with the US Army Medical Corp for almost six years. He holds a DEA License for controlled substances.
About W Technologies, Inc.
At this time, the Company's purpose is to seek, investigate and, if such investigation warrants, acquire an interest in business opportunities presented to it by persons or firms who or which desire to seek the perceived advantages of an Exchange Act registered corporation. The Company will not restrict its search to any specific business, industry or geographical location and the Company may participate in a business venture of virtually any kind or nature. This discussion of the proposed business is purposefully general and is not meant to be restrictive of the Company's virtually unlimited discretion to search for and enter into potential business opportunities.
The Company is continuing the review of several opportunities, especially in the field of medical CBD, with the intent to roll up into the Company any situation which results, after extensive review and due diligence, into a signed deal which can be consummated as a roll-up. The Company expects to have more information about specific situations within the next 30 days.
Forward-Looking Statements
Certain statements contained in this press release contain forward-looking statements within the meaning of the U.S. securities laws. Words such as "may," "would," "could," "should," "potential," "will," "seek," "intend," "plan," "anticipate," "believe," "estimate," "expect" and similar expressions as they relate to the Company, are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company's current views and intentions with respect to future events, based on information available to the Company, and are subject to certain risks, uncertainties and assumptions. While forward-looking statements are based on data, assumption and analyses that the Company believes are reasonable under the circumstances, whether actual results, performance or developments will meet the Company's expectations and predictions depends on a number of risks and uncertainties that could cause the actual results, performance and financial condition of the Company to differ materially from its expectations. Certain of the "risk factors" that could cause actual results to differ materially from the Company's forward-looking statements, if any, in this press release include, without limitation; general economic, market and business conditions and factors, including the risk factors discussed or referred to in the Company's Form 10 Registration Statement as filed with the U.S. Securities and Exchange Commission and available at www.sec.gov. Should any factor affect the Company in an unexpected manner or should assumptions underlying any such forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward look information. The forward-looking information included in this press release is made as of the date of this press release, and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.
CONTACT INFORMATION
W Technologies, Inc.
Mikael Lundgren, CEO
Tel: 424 522 9977
Cision View original content:http://www.prnewswire.com/news-releases/dr-edward-white-appointed-to-the-board-of-directors-of-w-technologies-inc-301240936.html
SOURCE W Technologies
Recent OLKR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 09:35:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:00:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/01/2023 08:46:40 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 10/31/2023 03:20:23 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 09/15/2023 06:37:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:05:47 PM
- OpenLocker Announces Launch of the OpenLocker Podcast Network to Connect Fans and Athletes for All of It's NIL Communities • InvestorsHub NewsWire • 05/19/2023 06:32:59 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM